NEW YORK (GenomeWeb) – Premaitha Health announced this week that it has signed two distribution deals to make its Iona non-invasive prenatal screening test available in the Middle East. The company's new customers, which it did not name, are establishing three laboratories in the region to act as regional hubs for the Iona test. Premaitha expects the labs to be opened during the second quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.